Sirtuins and Disease: The Road Ahead
Open Access
- 1 January 2012
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 3, 20774
Abstract
Sirtuins represent a promising new class of conserved histone deacetylases, originally identified in yeast. The activity of the sirtuin (SirT) family – made up of seven members (SirT1-7) – is NAD+ dependent. Sirtuins target a wide range of cellular proteins in nucleus, cytoplasm, and mitochondria for post-translational modification by acetylation (SirT1, 2, 3, and 5) or ADP-ribosylation (SirT4 and 6). Sirtuins regulate responses to stress and ensure that damaged DNA is not propagated, thus contrasting the accumulation of mutations. To date, sirtuins have emerged as potential therapeutic targets for treatment of human pathologies such as metabolic, cardiovascular and neurodegenerative diseases, and cancer. SirT1 is the founding member of this class of enzymes and is currently the best known of the group. SirT1 acts in various cellular processes, deacetylating both chromatin and non-histone proteins, and its role in cancer and aging has been extensively studied. SirT1 may play a critical role in tumor initiation and progression as well as drug resistance by blocking senescence and apoptosis, and by promoting cell growth and angiogenesis. Recently, growing interest in sirtuin modulation has led to the discovery and characterization of small molecules able to modify sirtuin activity. The present review highlights SirT mechanism(s) of action and deregulation in cancer, focusing on the therapeutic potential of SirT modulators both in cancer prevention and treatment.Keywords
This publication has 37 references indexed in Scilit:
- SIRT6 Promotes DNA Repair Under Stress by Activating PARP1Science, 2011
- Mammalian Sirt1: insights on its biological functionsCell Communication and Signaling, 2011
- SIRT3 Is a Mitochondria-Localized Tumor Suppressor Required for Maintenance of Mitochondrial Integrity and Metabolism during StressCancer Cell, 2010
- SIRT1, Is It a Tumor Promoter or Tumor Suppressor?International Journal of Biological Sciences, 2009
- The conserved role of sirtuins in chromatin regulationThe International Journal of Developmental Biology, 2009
- How does SIRT1 affect metabolism, senescence and cancer?Nature Reviews Cancer, 2008
- Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effectOncogene, 2008
- Impaired DNA Damage Response, Genome Instability, and Tumorigenesis in SIRT1 Mutant MiceCancer Cell, 2008
- A therapeutic role for sirtuins in diseases of aging?Trends in Biochemical Sciences, 2007
- Mechanism of Human SIRT1 Activation by ResveratrolJournal of Biological Chemistry, 2005